LAMIVUDINE (LAMIVUDINE) — FDA Approval ANDA204002 (AUROBINDO PHARMA USA)
LAMIVUDINE (LAMIVUDINE) — FDA Approval ANDA204002 (AUROBINDO PHARMA USA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LAMIVUDINE; Active ingredients: LAMIVUDINE; Application number: ANDA204002.
| Brand name | LAMIVUDINE |
|---|---|
| Active ingredients | LAMIVUDINE |
| Application number | ANDA204002 |
| Sponsor | AUROBINDO PHARMA USA |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20141231 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →